{"transactions":[{"id":4634114,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":33068,"kind":"person","name":"Philip Ron M","position":1,"cik":"0002063957","reported_name":"Philip Ron M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-03T00:15:27.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":1109,"price":12.29,"value":13629.61,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Plan in lieu of Board fees."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on September 30, 2026, and are 100% vested."}],"balance_after":1109,"derivative":{"exercise_price":15.33,"expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":1109},"source":{"system":"sec-edgar","filing":"0002063957-26-000009","document":"form4-10022026_041016.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063957/000206395726000009/form4-10022026_041016.xml","form_type":"4"}},{"id":718699,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":33068,"kind":"person","name":"Philip Ron M","position":1,"cik":"0002063957","reported_name":"Philip Ron M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T20:05:29.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":69,"price":15.04,"value":1037.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on June 30, 2026, and are 100% vested."}],"balance_after":69,"derivative":{"exercise_price":18.48,"expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":69},"source":{"system":"sec-edgar","filing":"0002063957-26-000007","document":"form4-07022026_040721.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063957/000206395726000007/form4-07022026_040721.xml","form_type":"4"}},{"id":726709,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":33068,"kind":"person","name":"Philip Ron M","position":1,"cik":"0002063957","reported_name":"Philip Ron M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T21:24:24.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":40200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in three substantially equal annual installments on the first, second and third anniversary of the date of grant, subject to the Eligible Director's continued service on each such vesting date."}],"balance_after":40200,"derivative":{"exercise_price":17.83,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":40200},"source":{"system":"sec-edgar","filing":"0002063957-26-000005","document":"form4-06252026_090620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063957/000206395726000005/form4-06252026_090620.xml","form_type":"4"}},{"id":775461,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":33068,"kind":"person","name":"Philip Ron M","position":1,"cik":"0002063957","reported_name":"Philip Ron M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-18T20:18:54.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":21872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":21872,"derivative":{"exercise_price":30.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":21872},"source":{"system":"sec-edgar","filing":"0002063957-26-000001","document":"form4-05182026_080551.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063957/000206395726000001/form4-05182026_080551.xml","form_type":"4"}},{"id":1145862,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":33068,"kind":"person","name":"Philip Ron M","position":1,"cik":"0002063957","reported_name":"Philip Ron M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-16T20:04:33.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":14522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":14522,"derivative":{"exercise_price":34.23,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":14522},"source":{"system":"sec-edgar","filing":"0001415889-25-013405","document":"form4-05162025_080525.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063957/000141588925013405/form4-05162025_080525.xml","form_type":"4"}},{"id":1177833,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":33068,"kind":"person","name":"Philip Ron M","position":1,"cik":"0002063957","reported_name":"Philip Ron M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-04-04T21:52:34.000Z","date":"2025-04-02","kind":"grant","planned":false,"acquired":true,"shares":14077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in 36 equal monthly installments beginning on May 2, 2025."}],"balance_after":14077,"derivative":{"exercise_price":32.53,"expiration_date":"2035-04-02","underlying":"Common Stock","underlying_shares":14077},"source":{"system":"sec-edgar","filing":"0001415889-25-010247","document":"form4-04042025_090430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063957/000141588925010247/form4-04042025_090430.xml","form_type":"4"}}]}